147983-18-4Relevant academic research and scientific papers
NOVEL BENZAMIDINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OSTEOPOROSIS COMPRISING THE SAME
-
Page/Page column 65, (2009/03/07)
The present invention relates to novel benzamidine derivatives, a process for the preparation thereof and a pharmaceutical composition for preventing or treating osteoporosis comprising the same. The benzamidine derivatives of the present invention effect
NOVEL BENZAMIDINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
-
Page/Page column 29-30, (2008/06/13)
The present invention relates to a novel benzamidine derivative, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The benzamidine derivative of the present invention effectively inhibits osteoclast differentiati
AN IMPROVED PROCESS FOR PREPARING N-HYDROXY-4-{5- [4- (5-ISOPROPYL-2-METHYL-l, 3-THIAZOL-4-YL) -PHENOXY] -PENTOXY }-BENZAMIDINE
-
Page/Page column 8; 13; 19-20, (2008/06/13)
This invention relates to an improved method of preparing N-hydroxy-4-{5- [4- (5-isopropyl-2-methyl-l, 3-thiazol-4-yl) phenoxy] pentoxy }benzamidine .
NOVEL BENZAMIDINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
-
Page/Page column 65-66, (2010/10/19)
The present invention relates to novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same. The novel benzamidine derivatives of the present invention are useful for the prevention and treatment of osteoporosis, bone fractures and allergic inflammatory diseases .
Hydroxyamidine derivatives
-
, (2008/06/13)
The invention relates to the compounds of the formula STR1 wherein the C(=NOH)-NH2 group may be in tautomeric form, and pharmaceutically acceptable salts thereof, in which: R1 is amino or amino which is mono- or disubstituted by a su
Arylethers, their manufacture and methods of treatment
-
, (2008/06/13)
The invention relates to the compounds of the formula STR1 wherein the C(=NH)--NHR group may be in tautomeric or isomeric form, and pharmaceutically acceptable salts thereof, in which: R is hydrogen or an acyl radical which is derived from an organic carb
